A 10‐year review of surgical management of dermatofibrosarcoma protuberans*
British Journal of Dermatology2020Vol. 184(4), pp. 731–739
Citations Over TimeTop 10% of 2020 papers
Alana Durack, Sonia Gran, Matthew D. Gardiner, Abhilash Jain, Emma Craythorne, Charlotte M. Proby, J. Marsden, Catherine Harwood, Rubeta Matin, the DFSP Collaborators, Andrew Affleck, Alaa Gh. Ahmed, Adeel Akhtar, Ravinder Atkar, Kamal Bisarya, Suchitra Chinthapalli, M. Chowdry, Rúben Coelho, Marwa M. Fawzy, L Hanna‐Bashara, Laura Hughes, Sheng Jing, Robin L. Jones, C. Kokkinos, Surendra Manam, Alicia K. Matthews, C McGrath, Charles D. Mitchell, Anna V. Murphy, Richard Pinder, Christine Scarsbrook, Kung‐Pei Tang, Zoe C Venables, James Warbrick‐Smith, Benjamin Way, Brie M. Wright
Abstract
WLE was the most common surgical modality used to treat DFSP across the UK. The local recurrence rate was very low, occurring only after WLE. Although a prospective randomized controlled trial may provide more definitive outcomes, in the absence of a clearly superior surgical modality, treatment decisions should be based on patient preference, clinical expertise and cost.
Related Papers
- → S1 guidelines for dermatofibrosarcoma protuberans (DFSP) – update 2018(2019)45 cited
- → Giant cell fibroblastoma mimicking a soft fibroma arising within a dermatofibrosarcoma protuberans(2012)5 cited
- [Recurrence of giant-cell fibroblastoma as dermatofibrosarcoma protuberans in the adult].(1996)
- [Giant cell fibroblastoma associated with Darier-Ferrand dermatofibrosarcoma in an adult].(1998)
- → Dermoscopy of Dermatofibrosarcoma Protuberans(2021)